Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
260.20    1.00 (0.39%)
Bid:
259.60
Ask:
260.20
Spread: 0.60 (0.231%)
Market Cap: £655.90m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Block listing Interim Review

1 Nov 2023 16:00

RNS Number : 0917S
Genuit Group PLC
01 November 2023
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 1 November 2023

 

Name of applicant:

Genuit Group plc

Name of scheme:

Genuit Group plc share option schemes

Period of return:

From:

1 May 2023

To:

31 October 2023

Balance of unallotted securities under scheme(s) from previous return:

500,000

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

500,000

 

Name of contact:

Colette Thompson, Assistant Company Secretary

Telephone number of contact:

+44 (0) 1138 315315

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRFLFEELALLIIV
Date   Source Headline
28th Apr 20224:07 pmRNSDirector/PDMR Shareholding
27th Apr 20224:31 pmRNSDirector/PDMR Shareholding
27th Apr 20221:32 pmRNSDirector/PDMR Shareholding
19th Apr 20229:43 amRNSNotice of AGM
12th Apr 20225:18 pmRNSHolding(s) in Company
11th Apr 20223:09 pmRNSHolding(s) in Company
4th Apr 20223:19 pmRNSHolding(s) in Company
30th Mar 20223:53 pmRNSBlock Listing Application
23rd Mar 20224:09 pmRNSDirector/PDMR Shareholding
22nd Mar 202211:57 amRNSBoard Committee changes
15th Mar 20227:00 amRNSFinal Results
10th Mar 20227:36 amRNSDirector Declaration
31st Jan 20223:10 pmRNSBoard changes update
9th Dec 20218:07 amRNSDirector Declaration
29th Nov 20218:01 amRNSDirectorate Change
16th Nov 20217:00 amRNSTrading Update
10th Nov 20218:02 amRNSDirector Declaration
1st Nov 20213:52 pmRNSBlock listing Interim Review
1st Nov 20218:43 amRNSDirector Declaration
29th Oct 202111:24 amRNSTotal Voting Rights
21st Oct 20214:11 pmRNSDirector/PDMR Shareholding
15th Oct 20215:07 pmRNSHolding(s) in Company
7th Oct 20217:31 amRNSDirector Declaration
8th Sep 202110:34 amRNSHolding(s) in Company
7th Sep 20213:17 pmRNSHolding(s) in Company
1st Sep 20214:00 pmRNSDirector/PDMR Shareholding
26th Aug 20215:14 pmRNSHolding(s) in Company
23rd Aug 20214:58 pmRNSHolding(s) in Company
20th Aug 202110:46 amRNSHolding(s) in Company
17th Aug 20217:00 amRNSHalf-year Report
28th May 20214:00 pmRNSTotal Voting Rights
24th May 20214:24 pmRNSDirector/PDMR Shareholding
20th May 202112:25 pmRNSResult of AGM
20th May 20217:01 amRNSBoard changes
20th May 20217:00 amRNSTrading Update
7th May 20215:23 pmRNSDirector/PDMR Shareholding
7th May 20215:00 pmRNSDirector/PDMR Shareholding
6th May 20215:28 pmRNSDirector/PDMR Shareholding
28th Apr 20214:11 pmRNSBlock Listing Application
19th Apr 20215:35 pmRNSNotice of AGM
8th Apr 20215:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.